stocknews1h
3 Healthcare Innovators Revolutionizing Patient Care
The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D ...
MassDevice1d
FemPulse wins FDA IDE for for overactive bladder neuromod
FemPulse announced today that it received FDA investigational device exemption (IDE) approval for its overactive bladder (OAB ...
FemPulse Receives FDA IDE Approval for the Pivotal Clinical Trial of its Wearable Bioelectronic Device for Overactive Bladder in Women
FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II pivotal clinical trial in female patients suffering ...
MassDevice1d
EndoQuest wins FDA IDE to study surgical robot in colorectal surgery
EndoQuest Robotics announced today that it received FDA investigational device exemption (IDE) for a study of its surgical ...
Endovascular Today1d
RapidPulse Receives IDE Approval for Pivotal Study of Its Cyclic Aspiration System for Ischemic Stroke
RapidPulse, Inc. announced FDA approval of an investigational device exemption (IDE) for the company to study the RapidPulse c ...
Becker's Spine Review1d
5 medtech notes: Smith+Nephew, Zavation and more
From a company layoff to FDA nods, here are five key developments from spine and orthopedic medtech companies since Dec. 4.
US FDA Grants Investigational Device Exemption (IDE) to EndoQuest™ Robotics for Its Flexible Robotic System
EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals ...
Endovascular Today3d
Study Finds Mortality and Rupture Are Uncommon After Elective FB-EVAR of Asymptomatic, Intact Thoracoabdominal Aortic Aneurysms
In a multicenter, prospective, nonrandomized study evaluating outcomes of fenestrated-branched endovascular aortic repair (FB ...